PRESS OFFICE
This Site All Sites
Welcome to Solvay Press Office

This site aims to provide an extensive and free-access toolbox to facilitate the professional coverage of Solvay news.
 
Members of the press can also contact Solvay spokespersons worldwide for further information and assistance.
 
 

 
  Latest news
May 08, 2008   Solvay to power its Bernburg (Germany) plant with secondary solid fuels
Energy generated from Refuse Derived Fuel Available in 2010
[EN]-[FR]-[NL]
   
April 25, 2008   SOLVAY PHARMACEUTICALS S.A. LAUNCHES FRIENDLY BID TO ACQUIRE INNOGENETICS
Building on a successful R&D co-operation
[EN]-[FR]-[NL]
   
March 31, 2008   Phase III studies of investigational Trilipix™ (SLV348/ABT-335), in combination with statins, meets primary endpoints on improving LDL, triglycerides and HDL
TriLipix™ in combination with statins improved all three key lipids and had reported safety consistent with TriLipix™ or statin monotherapies
[EN]-[FR]-[NL]
   
Other news
 09-05-2008 16:28 
91.66€ -0.93€
accueil
© Solvay S.A • Important information : Privacy policy  -  Disclaimer • If you have any comments, please contact the webmaster
Date of last update: 8/5/2008